Search results
Results From The WOW.Com Content Network
Genome Therapeutics Corporation. Genome Therapeutics Corp. was an early biotech company. It was founded in 1961 by Orrie M. Friedman under the name Collaborative Research Inc. [1] Under the leadership of Helen Donis-Keller and using internal funds, the company produced one of the first linkage maps of the whole human genome in the mid-1980s.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
NASDAQ Biotechnology Index. The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ -listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online .
Oscient Pharmaceuticals Corp. (OSCI) said Monday it and its wholly owned subsidiary, Guardian II Acquisition Corporation, each filed for Chapter 11 bankruptcy protection in the United States ...
By Puyaan Singh and Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit's drug for a chronic inflammatory liver ...
Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. [3] It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. [4] Depomed was founded in 1995 and is headquartered in Newark, California. [5] It is a publicly traded company on NASDAQ, with several ...
June 21, 2024 at 6:59 PM. (Reuters) - Ardent Health Partners disclosed a more than 5% rise in revenue for 2023 on Friday, as the healthcare provider revealed its paperwork for an initial public ...
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases . Its products include eculizumab (Soliris) and ravulizumab (Ultomiris), both used to treat the rare disorders of atypical hemolytic uremic ...